Time for Investors to Take the Plunge on Gilead Sciences Inc. (NASDAQ:GILD)

Equity Research firms currently have a positive stance on shares of Gilead Sciences Inc. (NASDAQ:GILD). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.20. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $103.50 on a short term basis.

At the time of writing, the stock was trading at $77.16. This represents a change from the opening price of -1.26%. In terms of performance, year to date, the stock is -21.61%. The monthly stock performance comes in at 1.40%. For the quarter, shares are performing at -6.42%. Weekly performance analysis shows the equity at -3.21%.

In taking a look at technical levels, shares are trading -2.80% away from the 50 day simple moving average and -10.77% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -29.09% away from it’s 52- week high and 1.25% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Gilead Sciences Inc.’s RSI stands at 40.30. In looking at volatility levels, the shares saw weekly volatility of 1.83% and 1.61% over the past month.

Leave a Comment